KRAS and EGFR mutations coexisting in lung adenocarcinoma

KRAS and EGFR mutations coexisting in lung adenocarcinoma

Bibliographic Details
Main Authors:	Sousa, Vitor, Alarcão, Ana, Couceiro, Patricia, Silva, Maria R, d’Aguiar, Maria J, Teixeira, Lia, Carvalho, Lina
Format:	Online
Language:	English
Published:	BioMed Central 2010
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255056/

Similar Items

EGFR unusual mutation status in lung adenocarcinomas
by: Alarcão, Ana, et al.
Published: (2010)

EGFR/erb-1, HER2/erb-2, CK7, LP34, Ki67 and p53 expression in preneoplastic lesions of bronchial epithelium
by: Carvalho, Lina, et al.
Published: (2010)

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
by: Planck, Maria, et al.
Published: (2013)

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers
by: TAKAMOCHI, KAZUYA, et al.
Published: (2013)

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
by: Brcic, Luka, et al.
Published: (2016)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
by: Smits, Alexander J. J., et al.
Published: (2012)

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
by: Choughule, A, et al.
Published: (2014)

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
by: Szablewski, Vanessa, et al.
Published: (2013)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
by: Wang, Lei, et al.
Published: (2014)

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
by: Li, S, et al.
Published: (2014)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
by: Ahn, Jin Woo, et al.
Published: (2014)

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
by: Wu, Shafei, et al.
Published: (2015)

KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas
by: Kim, Jeong-Oh, et al.
Published: (2015)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
by: Park, Jangchul, et al.
Published: (2016)

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
by: Unni, Arun M, et al.
Published: (2015)

MicroRNA-21 in lung cancer: overexpression in metastasis of pulmonary adenocarcinomas and squamous cell carcinomas
by: Silva, Maria R, et al.
Published: (2010)

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma
by: Berger, Alice H., et al.
Published: (2013)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
by: Cho, Jaeyoung, et al.
Published: (2016)

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
by: Pao, William, et al.
Published: (2005)

Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma
by: Elghissassi, Ibrahim, et al.
Published: (2014)

Rare coexistence of sarcoidosis and lung adenocarcinoma
by: Kachalia, Amit Girish, et al.
Published: (2014)

Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas
by: Bjaanæs, Maria Moksnes, et al.
Published: (2014)

The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
by: Hung, Ming-Szu, et al.
Published: (2016)

The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas
by: Shanzhi, Wan, et al.
Published: (2014)

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
by: Stanic, Karmen, et al.
Published: (2014)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
by: Krawczyk, Paweł, et al.
Published: (2013)

Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
by: Rong Jiang, et al.
Published: (2016-01-01)

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma
by: Ren, Yaoyao, et al.
Published: (2015)

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
by: Marino, Federica Zito, et al.
Published: (2015)

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation
by: Schaller, Alexandre, et al.
Published: (2014)

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
by: Dansin, Eric, et al.
Published: (2015)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
by: BUJKO, MATEUSZ, et al.
Published: (2014)

EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features
by: Jia, Xiaoli, et al.
Published: (2015)

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
by: Ramteke, Manoj P., et al.
Published: (2016)

Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
by: Lee, Boram, et al.
Published: (2016)

Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome
by: Kerner, Gerald S. M. A., et al.
Published: (2013)

Frequent Mutations in EGFR, KRAS and TP53 Genes in Human Lung Cancer Tumors Detected by Ion Torrent DNA Sequencing
by: Cai, Xin, et al.
Published: (2014)

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
by: Tomasini, Pascale, et al.
Published: (2016)

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
by: PAPADOPOULOU, EIRINI, et al.
Published: (2015)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
by: Lee, Taebum, et al.
Published: (2016)